NR1I2 and cancer: On top of that, the impact of PXR is also reported in many hematological malignancies and various cancers of the gastrointestinal system, such as liver, esophagus, colon, and pancreas cancer, as well as in the breast, endometrium, cervix, ovaries, lung, and prostate.